Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in Acta Haematol

Retrieve available abstracts of 37 articles:
HTML format
Text format

Single Articles

    January 2017
  1. QUINTELA A, Sujobert P, Callet-Bauchu E, Salles G, et al
    Ibrutinib-Induced Lymphocytosis: Cytological Features.
    Acta Haematol. 2017;137:55-57.
    PubMed     Text format    

  2. LONGU F, Fozza C, Dessi L, Longinotti M, et al
    Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.
    Acta Haematol. 2017;137:15-16.
    PubMed     Text format    

    November 2016
  3. SHENG G, Zeng Z, Pan J, Wang Q, et al
    t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.
    Acta Haematol. 2016;137:40-43.
    PubMed     Text format    

    October 2016
  4. MORI N, Ohwashi-Miyazaki M, Okada M, Yoshinaga K, et al
    Translocation (9;12)(q34.1;p13.3) Resulted in ETV6-ABL1 Fusion in a Patient with Philadelphia Chromosome-Negative Chronic Myelogenous Leukemia.
    Acta Haematol. 2016;136:240-243.
    PubMed     Text format    

    September 2016
  5. BALJEVIC M, Dumitriu B, Lee JW, Paietta EM, et al
    Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.
    Acta Haematol. 2016;136:210-218.
    PubMed     Text format     Abstract available

    August 2016
  6. HULEGARDH E, Punab M, Holmberg E, Palk K, et al
    Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years.
    Acta Haematol. 2016;136:167-173.
    PubMed     Text format     Abstract available

  7. KAMODA Y, Izumi K, Iioka F, Akasaka T, et al
    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution.
    Acta Haematol. 2016;136:157-166.
    PubMed     Text format     Abstract available

    May 2016
  8. BYUN JM, Lee JO, Bang SM, Yu ES, et al
    8p11 Myeloproliferative Syndrome with t(7;8) Translocation Presenting as Acute Myeloid Leukemia: A Case Report and Literature Review.
    Acta Haematol. 2016;136:71-75.
    PubMed     Text format    

    April 2016
  9. YAN W, Zhang G
    Molecular Characteristics and Clinical Significance of 12 Fusion Genes in Acute Promyelocytic Leukemia: A Systematic Review.
    Acta Haematol. 2016;136:1-15.
    PubMed     Text format     Abstract available

    March 2016
  10. LI X, Zhu H, Zhang Y, Zhao W, et al
    The Time to Clearance of Peripheral Blood Blasts Predicts Complete Remission and Survival in Chinese Adults with Acute Myeloid Leukemia.
    Acta Haematol. 2016;135:217-223.
    PubMed     Text format     Abstract available

    January 2016
  11. SHACHAM-ABULAFIA A, Itchaki G, Yeshurun M, Paul M, et al
    High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2016;135:55-64.
    PubMed     Text format     Abstract available

  12. MUSTO P
    Novel Agents for the Treatment of Primary Plasma-Cell Leukemia: Lights and Shadows.
    Acta Haematol. 2016;135:110-112.
    PubMed     Text format    

  13. IRIUCHISHIMA H, Ozaki S, Konishi J, Matsumoto M, et al
    Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma.
    Acta Haematol. 2016;135:113-121.
    PubMed     Text format     Abstract available

    High-Intensity Induction in the Elderly.
    Acta Haematol. 2016;135:53-4.
    PubMed     Text format    

  15. FARINA M, Rossi G, Bellotti D, Marchina E, et al
    Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia.
    Acta Haematol. 2016;135:39-42.
    PubMed     Text format     Abstract available

  16. KAEDA J, Ringel F, Oberender C, Gresse M, et al
    Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2016;136:62-4.
    PubMed     Text format    

  17. SANTOLERI F, Lasala R, Ranucci E, La Barba G, et al
    Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.
    Acta Haematol. 2016;136:45-51.
    PubMed     Text format     Abstract available

  18. AMITAI I, Leader A, Raanani P
    Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead.
    Acta Haematol. 2016;136:43-4.
    PubMed     Text format    

  19. NORSWORTHY KJ, Bhatnagar B, Singh ZN, Gojo I, et al
    Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the Literature.
    Acta Haematol. 2016;135:241-51.
    PubMed     Text format     Abstract available

    L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity.
    Acta Haematol. 2016;135:208-10.
    PubMed     Text format     Abstract available

  21. SHANSHAL M, Shakespeare A, Thirumala S, Fenton B, et al
    Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the Literature.
    Acta Haematol. 2016;136:219-228.
    PubMed     Text format     Abstract available

  22. GONG D, Li W, Hu LD, Shen JL, et al
    Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China.
    Acta Haematol. 2016;136:201-209.
    PubMed     Text format     Abstract available

  23. ZHANG G, Dong F, Luan C, Zhang X, et al
    Overexpression of CCAAT Enhancer-Binding Protein alpha Inhibits the Growth of K562 Cells via the Foxo3a-Bim Pathway.
    Acta Haematol. 2016;136:65-70.
    PubMed     Text format     Abstract available

    November 2015
    The Importance of Being Cured: A Chronic Myeloid Leukemia Perspective.
    Acta Haematol. 2015;135:131-132.
    PubMed     Text format    

  25. YHIM HY, Lee NR, Song EK, Yim CY, et al
    Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease.
    Acta Haematol. 2015;135:133-139.
    PubMed     Text format     Abstract available

    July 2015
  26. GRZYWNOWICZ M, Karczmarczyk A, Skorka K, Zajac M, et al
    Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia.
    Acta Haematol. 2015;134:255-262.
    PubMed     Text format     Abstract available

  27. RIBEIRO BF, Vergilio BR, Miranda EC, Almeida MH, et al
    BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institut
    Acta Haematol. 2015;134:248-254.
    PubMed     Text format     Abstract available

    Chronic Myeloid Leukemia Monitoring after Imatinib Failure: Still More Questions than Answers.
    Acta Haematol. 2015;134:246-247.
    PubMed     Text format    

    June 2015
  29. CAPELA DE MATOS RR, De Figueiredo AF, Liehr T, Alhourani E, et al
    A Novel Three-Way Variant t(8;13;21)(q22;q33;q22) in a Child with Acute Myeloid Leukemia with RUNX1/RUNX1T1 : The Contribution of Molecular Approaches for Revealing t(8;21) Variants.
    Acta Haematol. 2015;134:243-245.
    PubMed     Text format    

  30. NOVAK M, Prochazka V, Turcsanyi P, Papajik T, et al
    Numbers of CD8+PD-1+ and CD4+PD-1+ Cells in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Are Independent of Binet Stage and Are Significantly Higher Compared to Healthy Volunteers.
    Acta Haematol. 2015;134:208-214.
    PubMed     Text format     Abstract available

    May 2015
  31. ALSHEHRY NF, Al-Huneini M, Lipton JH, Michelis FV, et al
    Lymphoproliferative Disorders in Patients with Chronic Myeloid Leukemia: A Single-Center Case Series.
    Acta Haematol. 2015;134:161-167.
    PubMed     Text format     Abstract available

    January 2015
  32. KHASPEKOVA SG, Shustova ON, Golubeva NV, Vasiliev SA, et al
    Relationships of mean platelet volume and plasma thrombopoietin with glycocalicin levels in thrombocytopenic patients.
    Acta Haematol. 2015;133:295-9.
    PubMed     Text format     Abstract available

  33. XIANG L, Wang R, Wei J, Qiu G, et al
    Retinoic acid receptor-beta gene reexpression and biological activity in SHI-1 cells after combined treatment with 5-aza-2'-deoxycytidine and all-trans retinoic acid.
    Acta Haematol. 2015;133:279-86.
    PubMed     Text format     Abstract available

  34. SUNG HJ, Lee SR, Choi IK, Park Y, et al
    Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage.
    Acta Haematol. 2015;134:59-68.
    PubMed     Text format     Abstract available

  35. ZHENG X, Guo Y, Chen Y, Chen M, et al
    Knockdown of Adhesion-Regulating Molecule 1 Inhibits Proliferation in HL60 Cells.
    Acta Haematol. 2015;134:88-100.
    PubMed     Text format     Abstract available

  36. SHENOY N
    Is ADRM1 a Good Target for Cancer Therapy?
    Acta Haematol. 2015;134:86-7.
    PubMed     Text format    

  37. MOLINOS-QUINTANA A, Aquino V, Montero I, Perez-de Soto C, et al
    Emerging BCR/ABL1 Mutations Under Treatment with Tyrosine Kinase Inhibitors in Paediatric Acute Lymphoblastic Leukaemia.
    Acta Haematol. 2015;134:71-5.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.